145,16 €
161,29 €
-10% with code: EXTRA
Meyler's Side Effects of Drugs Used in Cancer and Immunology
145,16 € 
- We will send in 10–14 business days.
Elsevier now offers a series of derivative works based on the acclaimed Meyler's Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. There has been significant progress in the development of targeted therapy drugs that act specifically on certain cancers, and that minimize damage to normal cells. Oncologists and cancer researchers will rely on this volume to determine effective drug treatments.
/images/books/3469866/9780444532671.jpg)
- Publisher: Elsevier Science
- ISBN-10: 0444532676
- ISBN-13: 9780444532671
- Format: 20.8 x 28.5 x 4.6 cm, kieti viršeliai
- Language: English
- SAVE -10% with code: EXTRA
Meyler's Side Effects of Drugs Used in Cancer and Immunology (e-book) (used book) | bookbook.eu
Reviews
Description
Elsevier now offers a series of derivative works based on the acclaimed Meyler's Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician.
There has been significant progress in the development of targeted therapy drugs that act specifically on certain cancers, and that minimize damage to normal cells. Oncologists and cancer researchers will rely on this volume to determine effective drug treatments.EXTRA 10 % discount with code: EXTRA
145,16 €
161,29 €
We will send in 10–14 business days.
The promotion ends in 21d.05:42:22
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Elsevier Science
- ISBN-10: 0444532676
- ISBN-13: 9780444532671
- Format: 20.8 x 28.5 x 4.6 cm, kieti viršeliai
- Language: English English
Elsevier now offers a series of derivative works based on the acclaimed Meyler's Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician.
There has been significant progress in the development of targeted therapy drugs that act specifically on certain cancers, and that minimize damage to normal cells. Oncologists and cancer researchers will rely on this volume to determine effective drug treatments.
Reviews